Propoxyphene Use by Community‐Dwelling and Institutionalized Elderly Medicare Beneficiaries

Kamal-Bahl, Sachin; Doshi, Jalpa A.; Stuart, Bruce; Briesacher, Becky A.

doi:10.1046/j.1532-5415.2003.51358.x

Cited by 29 publications

(13 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 A study comparing propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries demonstrated that not only was propoxyphene use by community-dwelling seniors high, its usage is much higher in the institutionalized population. 5 Opioid adverse drug events (ADEs) are also a concern. Two large studies suggest that, in the populations of hospitalized patients, opioid ADEs occur at a rate of 2.9% and 3.7%.…”

Section: Introductionmentioning

confidence: 99%

Opioid Expenditures and Utilization in the Medicaid System

Brixner¹,

Oderda²,

Roland

et al. 2006

J. Of Pain & Palliative Care Pharmacotherapy

View full text Add to dashboard Cite

Data from the U.S. Centers for Medicare and Medicaid Services' Medicaid database were analyzed to define recent trends in the use and cost of opioid medications United States as a whole and in seven states between 1998 and 2003. Over this time period, total Medicaid prescriptions for opioids have nearly doubled and, in nominal terms, expenditures have nearly tripled. The morphine derivatives account for the largest share of these increases. By 2003, opioids represented about a four percent share of all Medicaid prescription drugs. Variations among the states in per-enrollee spending on opioids are substantial. The appropriateness of these variations is unknown.

show abstract

Section: Introductionmentioning

confidence: 99%

Opioid Expenditures and Utilization in the Medicaid System

Brixner¹,

Oderda²,

Roland

et al. 2006

J. Of Pain & Palliative Care Pharmacotherapy

View full text Add to dashboard Cite

show abstract

“…To the Editor: Using the 1998 Medicare Current Beneficiary Survey, Kamal‐Bahl et al 1 found that the elderly commonly use propoxyphene, particularly in long‐term care facilities. This study was predicated on the assumption that propoxyphene prescribing is inappropriate.…”

mentioning

confidence: 99%

Criteria for Prescribing Require Further Study

Goldstein

2004

J American Geriatrics Society

View full text Add to dashboard Cite

“…To the Editor: Our study was designed to estimate and compare the use of propoxyphene by elderly Medicare beneficiaries living in the community and institutions 1 . We identified propoxyphene as potentially inappropriate for use in adults aged 65 and older from numerous pain management guidelines as well as published lists of medications deemed potentially inappropriate by national expert panels 2–7 .…”

mentioning

confidence: 99%